Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network

Por Boult, J K R, Tanière, P, Hallissey, M T, Campbell, M J, Tselepis, C
Publicado em 2008

The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function

Por Baker, L C J, Boult, J K R, Walker-Samuel, S, Chung, Y-L, Jamin, Y, Ashcroft, M, Robinson, S P
Publicado em 2012

The role of tumour-derived iNOS in tumour progression and angiogenesis

Por Kostourou, V, Cartwright, J E, Johnstone, A P, Boult, J K R, Cullis, E R, Whitley, GStJ, Robinson, S P
Publicado em 2011

Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography

Por Li, J, Jamin, Y, Boult, J K R, Cummings, C, Waterton, J C, Ulloa, J, Sinkus, R, Bamber, J C, Robinson, S P
Publicado em 2014

False-negative MRI biomarkers of tumour response to targeted cancer therapeutics

Por Boult, J K R, Jamin, Y, Jacobs, V, Gilmour, L D, Walker-Samuel, S, Halliday, J, Elvin, P, Ryan, A J, Waterton, J C, Robinson, S P
Publicado em 2012

Dichloroacetate induces autophagy in colorectal cancer cells and tumours

Por Lin, G, Hill, D K, Andrejeva, G, Boult, J K R, Troy, H, Fong, A-C L F W T, Orton, M R, Panek, R, Parkes, H G, Jafar, M, Koh, D-M, Robinson, S P, Judson, I R, Griffiths, J R, Leach, M O, Eykyn, T R, Chung, Y-L
Publicado em 2014